Has Tara Taylor received payments from drug or device companies?

Yes. Drug and device makers reported $2,102 in general payments to Tara Taylor across 67 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tara Taylor did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tara Taylor come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tara Taylor

Critical Care Medicine · Tyler, TXNPI 1912931213

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.2% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,560, more than ten times the $82 reported in 2019.

$2,102in general payments, 2019–2025

Across 67 payments — averaging $31.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$333
Actelion Pharmaceuticals US, Inc.$191
GSK$183
Johnson & Johnson$153
Sanofi$150
Inspire Medical Systems, Inc.$144
plus $947 from 15 others

What the payments were for

Food & beverage$2,00295%
Education$1005%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	12	$333
Actelion Pharmaceuticals US, Inc.	7	$191
GSK	7	$183
Johnson & Johnson(2 entities)	2	$153
Sanofi	6	$150
Inspire Medical Systems, Inc.	2	$144
Abiomed	1	$141
Regeneron Healthcare Solutions, Inc.	7	$126
Sanofi-aventis U.S. LLC	1	$100
KCI USA, Inc.	1	$82
Viatris Specialty LLC	3	$76
Merck	2	$62
Mallinckrodt Hospital Products Inc.	2	$58
Boehringer Ingelheim	3	$56
United Therapeutics Corporation	2	$54
ANI Pharmaceuticals, Inc.	2	$47
Takeda Pharmaceuticals U.S.A., Inc.	1	$37
Verona Pharma, Inc.	2	$37
Grifols USA, LLC	2	$33
Insmed, Inc.	1	$23
Harmony Biosciences LLC	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,102 in reported general payments places this provider in the 75th percentile of 507 critical care medicine providers in Texas.

See all critical care medicine providers in Texas →

Other critical care medicine in Tyler

David JonesTyler$9K
Steven DavidoffPlano$364K
William BartekAustin$284K
Edwin ParsleyHouston$283K
Hector PayanEl Paso$245K
Bindu AkkantiHouston$185K
Faisal MasudHouston$155K
Sergio Trevino CastilloHouston$133K
Akinyinka AjelabiKingwood$109K
Anthony OrtegonDallas$106K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →